301166 优宁维
已收盘 10-08 15:00:00
资讯
新帖
简况
股市必读：优宁维新发布《关于回购公司股份的进展公告》
证券之星 · 02:19
股市必读：优宁维新发布《关于回购公司股份的进展公告》
优宁维（301166）9月30日主力资金净买入1590.04万元
证券之星 · 10-08 09:02
优宁维（301166）9月30日主力资金净买入1590.04万元
优宁维（301166）9月23日主力资金净卖出199.93万元
证券之星 · 09-24
优宁维（301166）9月23日主力资金净卖出199.93万元
优宁维：9月16日召开业绩说明会，投资者参与
证券之星 · 09-16
优宁维：9月16日召开业绩说明会，投资者参与
股市必读：优宁维新发布《关于参加2026年上海辖区上市公司集体接待日暨中报业绩说明会活动的公告》
证券之星 · 09-11
股市必读：优宁维新发布《关于参加2026年上海辖区上市公司集体接待日暨中报业绩说明会活动的公告》
优宁维扣非连亏2年半 2021上市超募13亿国联民生保荐
中金财经 · 09-08
优宁维扣非连亏2年半 2021上市超募13亿国联民生保荐
优宁维（301166）披露回购公司股份进展公告，9月1日股价上涨0.44%
证券之星 · 09-01
优宁维（301166）披露回购公司股份进展公告，9月1日股价上涨0.44%
【投融资动态】宇测生物B轮融资，融资额超5000万人民币，投资方为泰州战新私募基金、优宁维等
证券之星 · 09-01
【投融资动态】宇测生物B轮融资，融资额超5000万人民币，投资方为泰州战新私募基金、优宁维等
优宁维（301166）披露2026年半年度报告，8月31日股价下跌0.85%
证券之星 · 08-31
优宁维（301166）披露2026年半年度报告，8月31日股价下跌0.85%
优宁维（301166）2026年中报简析：营收上升亏损收窄，盈利能力上升
证券之星 · 08-30
优宁维（301166）2026年中报简析：营收上升亏损收窄，盈利能力上升
优宁维(301166)6月30日股东户数0.95万户，较上期减少18.45%
证券之星 · 08-29
优宁维(301166)6月30日股东户数0.95万户，较上期减少18.45%
图解优宁维中报：第二季度单季净利润同比增长53.99%
证券之星 · 08-29
图解优宁维中报：第二季度单季净利润同比增长53.99%
破发股优宁维跌10.04% 2021年上市超募13亿国联民生保荐
中金财经 · 08-21
破发股优宁维跌10.04% 2021年上市超募13亿国联民生保荐
优宁维（301166）披露完成工商变更登记公告，8月19日股价下跌3.14%
证券之星 · 08-19
优宁维（301166）披露完成工商变更登记公告，8月19日股价下跌3.14%
破发股优宁维跌2.98%2021年上市超募13亿国联民生保荐
中金财经 · 08-18
破发股优宁维跌2.98%2021年上市超募13亿国联民生保荐
股市必读：优宁维新发布《第一期员工持股计划第一次持有人会议决议公告》
证券之星 · 08-10
股市必读：优宁维新发布《第一期员工持股计划第一次持有人会议决议公告》
股市必读：优宁维新发布《关于回购公司股份的进展公告》
证券之星 · 08-04
股市必读：优宁维新发布《关于回购公司股份的进展公告》
股市必读：优宁维（301166）7月29日董秘有最新回复
证券之星 · 07-30
股市必读：优宁维（301166）7月29日董秘有最新回复
优宁维：公司围绕抗体及相关领域，寻找与公司业务具有协同效应的上下游企业
证券之星 · 07-29
优宁维：公司围绕抗体及相关领域，寻找与公司业务具有协同效应的上下游企业
优宁维（301166）披露第一期员工持股计划非交易过户完成公告，7月28日股价下跌1.33%
证券之星 · 07-28
优宁维（301166）披露第一期员工持股计划非交易过户完成公告，7月28日股价下跌1.33%
公司概况
公司名称：
上海优宁维生物科技股份有限公司
所属行业：
批发业
上市日期：
2021-12-28
主营业务：
上海优宁维生物科技股份有限公司的主营业务是提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。公司的主要产品是生命科学试剂及相关仪器、耗材、综合技术服务。
发行价格：
86.06
{"stockData":{"symbol":"301166","market":"SZ","secType":"STK","nameCN":"优宁维","latestPrice":35.11,"timestamp":1791443031000,"preClose":35.35,"halted":0,"volume":5172731,"delay":0,"changeRate":-0.0068,"floatShares":56420500,"shares":86168500,"eps":-0.248,"marketStatus":"已收盘","change":-0.24,"latestTime":"10-08 15:00:00","open":35.31,"high":36.19,"low":34.5,"amount":182000000,"amplitude":0.0478,"askPrice":35.15,"askSize":17,"bidPrice":35.11,"bidSize":20,"shortable":0,"etf":0,"ttmEps":-0.248,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791509400000},"marketStatusCode":5,"adr":0,"adjPreClose":35.35,"symbolType":"stock","openAndCloseTimeList":[[1791423000000,1791430200000],[1791435600000,1791442800000]],"highLimit":38.89,"lowLimit":31.82,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":86168468,"isCdr":false,"pbRate":1.57,"roa":"--","roe":"--","epsLYR":-0.26,"committee":0.060241,"marketValue":3025000000,"turnoverRate":0.0917,"status":1,"floatMarketCap":1981000000},"requestUrl":"/m/hq/s/301166/wiki","defaultTab":"wiki","newsList":[{"id":"2674057004","title":"股市必读：优宁维新发布《关于回购公司股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674057004","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674057004?lang=zh_cn&edition=full","pubTime":"2026-10-09 02:19","pubTimestamp":1791483549,"startTime":"0","endTime":"0","summary":"截至2026年10月8日收盘，优宁维报收于35.11元，下跌0.68%，换手率9.17%，成交量5.17万手，成交额1.82亿元。当日关注点交易信息汇总：10月8日主力资金净流入382.12万元，占总成交额2.1%。公司公告汇总：截至2026年9月30日，优宁维已累计回购291,100股，占总股本0.34%，支付总金额7,496,566元，回购价格区间为24.16元/股至28.00元/股，回购价格上限已调整为不超过44.41元/股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900002199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673049233","title":"优宁维（301166）9月30日主力资金净买入1590.04万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673049233","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673049233?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:02","pubTimestamp":1791421348,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月30日收盘，优宁维报收于35.35元，上涨7.25%，换手率8.24%，成交量4.65万手，成交额1.62亿元。近5日资金流向一览见下表：优宁维融资融券信息显示，融资方面，当日融资买入1783.67万元，融资偿还1211.76万元，融资净买入571.91万元。优宁维主营业务：公司面向高等院校、科研院所、医院和生物医药企业等,提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800002861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669943012","title":"优宁维（301166）9月23日主力资金净卖出199.93万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669943012","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669943012?lang=zh_cn&edition=full","pubTime":"2026-09-24 09:09","pubTimestamp":1790212184,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月23日收盘，优宁维报收于33.03元，上涨2.67%，换手率5.26%，成交量2.97万手，成交额9709.87万元。近5日资金流向一览见下表：优宁维融资融券信息显示，融资方面，当日融资买入751.0万元，融资偿还804.78万元，融资净偿还53.78万元。优宁维主营业务：公司面向高等院校、科研院所、医院和生物医药企业等,提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400009005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667857869","title":"优宁维：9月16日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2667857869","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667857869?lang=zh_cn&edition=full","pubTime":"2026-09-16 21:04","pubTimestamp":1789563890,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年9月16日优宁维发布公告称公司于2026年9月16日召开业绩说明会。相关进展投资者可关注公司披露的相关临时公告和定期报告。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600035785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666590163","title":"股市必读：优宁维新发布《关于参加2026年上海辖区上市公司集体接待日暨中报业绩说明会活动的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666590163","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666590163?lang=zh_cn&edition=full","pubTime":"2026-09-11 02:08","pubTimestamp":1789063695,"startTime":"0","endTime":"0","summary":"公司公告汇总：优宁维将于2026年9月16日15:00–17:00通过“全景路演”平台举行中报业绩说明会，董事长兼总经理冷兆武等高管将在线交流。公司公告汇总关于参加2026年上海辖区上市公司集体接待日暨中报业绩说明会活动的公告上海优宁维生物科技股份有限公司将参加由中国证券监督管理委员会上海监管局指导、上海上市公司协会及深圳市全景网络有限公司联合举办的“2026年上海辖区上市公司集体接待日暨中报业绩说明会活动”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100002573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665932885","title":"优宁维扣非连亏2年半 2021上市超募13亿国联民生保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2665932885","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665932885?lang=zh_cn&edition=full","pubTime":"2026-09-08 15:05","pubTimestamp":1788851103,"startTime":"0","endTime":"0","summary":"中国经济网北京9月8日讯 优宁维 近期发布2026年半年度报告。 优宁维2024年至2025年归属于上市公司股东的净利润分别为1014.90万元、-2294.87万元；归属于上市公司股东的扣除非经常性损益的净利润分别为-1511.00万元、-4321.38万元。 优宁维首次公开发行股票发行费用合计2.69亿元，其中，承销及保荐费用2.48亿元。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/08/20260908921332.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/08/20260908921332.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260908/32363254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0276","301166","IPOS","BK1564","01456","601456","BK0250","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664485035","title":"优宁维（301166）披露回购公司股份进展公告，9月1日股价上涨0.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664485035","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664485035?lang=zh_cn&edition=full","pubTime":"2026-09-01 23:08","pubTimestamp":1788275297,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，优宁维报收于29.4元，较前一交易日上涨0.44%，最新总市值为25.33亿元。该股当日开盘29.27元，最高29.66元，最低29.06元，成交额达5171.81万元，换手率为3.12%。优宁维于近日披露《关于回购公司股份的进展公告》。回购价格上限已由45元/股调整为44.41元/股。本次回购符合相关规定，公司后续将在回购期限内继续实施回购计划并履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100043595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664194855","title":"【投融资动态】宇测生物B轮融资，融资额超5000万人民币，投资方为泰州战新私募基金、优宁维等","url":"https://stock-news.laohu8.com/highlight/detail?id=2664194855","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664194855?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:26","pubTimestamp":1788262017,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP于8月31日公布的信息整理，苏州宇测生物科技有限公司B轮融资，融资额超5000万人民币，参与投资的机构包括泰州战新私募基金，优宁维，领航新界。苏州宇测生物科技有限公司成立于2019年，是实现单分子免疫检测技术产业化的高新技术型公司，核心技术具备完全自主知识产权，成功填补了国内这一领域发展前沿的空白。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100036730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","MCNHmain","BK0250","CNHmain","UCmain","CYB","MUCmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663807013","title":"优宁维（301166）披露2026年半年度报告，8月31日股价下跌0.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663807013","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663807013?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:34","pubTimestamp":1788176085,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，优宁维报收于29.27元，较前一交易日下跌0.85%，最新总市值为25.22亿元。该股当日开盘29.63元，最高29.7元，最低28.9元，成交额达6089.34万元，换手率为3.7%。优宁维于2026年8月29日披露《2026年半年度报告摘要》。经营活动产生的现金流量净额为-162,553,279.27元，较上年同期减少164.15%。报告期末，公司总资产为2,250,670,220.06元，较上年度末下降2.25%；归属于上市公司股东的净资产为1,934,086,457.81元，较上年度末下降3.58%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100031471.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663604801","title":"优宁维（301166）2026年中报简析：营收上升亏损收窄，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2663604801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663604801?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:33","pubTimestamp":1788042807,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期优宁维发布2026年中报。截至本报告期末，公司营业总收入5.69亿元，同比上升12.62%，归母净利润-1179.58万元，同比上升11.84%。本报告期优宁维盈利能力上升，毛利率同比增幅13.53%，净利率同比增幅21.72%。财报体检工具显示：建议关注公司现金流状况建议关注公司应收账款状况本文数据来源于优宁维2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000003307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663012102","title":"优宁维(301166)6月30日股东户数0.95万户，较上期减少18.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663012102","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663012102?lang=zh_cn&edition=full","pubTime":"2026-08-29 17:20","pubTimestamp":1787995223,"startTime":"0","endTime":"0","summary":"证券之星消息，近日优宁维披露，截至2026年6月30日公司股东户数为9482.0户，较3月31日减少2145.0户，减幅为18.45%。在生物制品行业个股中，优宁维股东户数低于行业平均水平，截至6月30日，生物制品行业平均股东户数为3.54万户。从股价来看，2026年3月31日至2026年6月30日，优宁维区间跌幅为12.64%，在此期间股东户数减少2145.0户，减幅为18.45%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900023983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663401356","title":"图解优宁维中报：第二季度单季净利润同比增长53.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663401356","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663401356?lang=zh_cn&edition=full","pubTime":"2026-08-29 03:41","pubTimestamp":1787946107,"startTime":"0","endTime":"0","summary":"证券之星消息，优宁维2026年中报显示，上半年度公司主营收入5.69亿元，同比上升12.62%；归母净利润-1179.58万元，同比上升11.84%；扣非净利润-1751.92万元，同比上升15.3%；其中2026年第二季度，公司单季度主营收入3.09亿元，同比上升7.2%；单季度归母净利润-329.95万元，同比上升53.99%；单季度扣非净利润-650.44万元，同比上升42.94%；负债率14.07%，投资收益236.82万元，财务费用-165.75万元，毛利率20.59%。财报数据概要请见下图:本文数据来源于优宁维2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900007583.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661663402","title":"破发股优宁维跌10.04% 2021年上市超募13亿国联民生保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2661663402","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661663402?lang=zh_cn&edition=full","pubTime":"2026-08-21 16:54","pubTimestamp":1787302445,"startTime":"0","endTime":"0","summary":"中国经济网北京8月21日讯 优宁维 今日收报30.64元，跌幅10.04%。 优宁维于2021年12月28日在深交所创业板上市，公开发行股票2166.67万股，发行价格为86.06元/股，保荐机构为国联民生，保荐代表人为梁军、卞进。 优宁维首次公开发行股票募集资金总额为18.65亿元，扣除发行费用后，募集资金净额为15.96亿元。优宁维最终募集资金净额比原计划多13.12亿元。 优宁维首次公开发行股票发行费用合计2.69亿元，其中，承销及保荐费用2.48亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260821/32342831.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["601456","BK1147","IPOS","BK1564","01456","BK0276","301166","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660429754","title":"优宁维（301166）披露完成工商变更登记公告，8月19日股价下跌3.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660429754","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660429754?lang=zh_cn&edition=full","pubTime":"2026-08-19 22:30","pubTimestamp":1787149835,"startTime":"0","endTime":"0","summary":"截至2026年8月19日收盘，优宁维报收于28.38元，较前一交易日下跌3.14%，最新总市值为24.45亿元。近日，优宁维披露《关于完成工商变更登记的公告》。公告显示，公司于2026年5月26日召开第四届董事会第十三次会议，于2026年6月16日召开2026年第二次临时股东会，审议通过了关于变更公司经营范围、修订《公司章程》并办理工商变更登记的议案。公司已办理完毕工商变更登记手续，并取得上海市市场监督管理局换发的营业执照。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900043404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660468292","title":"破发股优宁维跌2.98%2021年上市超募13亿国联民生保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2660468292","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660468292?lang=zh_cn&edition=full","pubTime":"2026-08-18 16:29","pubTimestamp":1787041743,"startTime":"0","endTime":"0","summary":"中国经济网北京8月18日讯 优宁维 今日收报29.30元，跌幅2.98%。 优宁维于2021年12月28日在深交所创业板上市，公开发行股票2166.67万股，发行价格为86.06元/股，保荐机构为国联民生，保荐代表人为梁军、卞进。 优宁维首次公开发行股票募集资金总额为18.65亿元，扣除发行费用后，募集资金净额为15.96亿元。 优宁维首次公开发行股票发行费用合计2.69亿元，其中，承销及保荐费用2.48亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260818/32338527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["01456","BK0250","301166","BK0276","BK1564","IPOS","601456","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658560888","title":"股市必读：优宁维新发布《第一期员工持股计划第一次持有人会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658560888","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658560888?lang=zh_cn&edition=full","pubTime":"2026-08-10 02:02","pubTimestamp":1786298538,"startTime":"0","endTime":"0","summary":"公司公告汇总：优宁维于8月6日召开第一期员工持股计划第一次持有人会议，审议通过设立管理委员会并选举肖菲、陆志文、夏庆立为委员，夏庆立任主任；授权管理委员会办理计划日常管理、权益处置等全部事宜，议案全票通过。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000000884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656068553","title":"股市必读：优宁维新发布《关于回购公司股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656068553","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656068553?lang=zh_cn&edition=full","pubTime":"2026-08-04 02:09","pubTimestamp":1785780552,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘，优宁维报收于25.8元，上涨2.58%，换手率2.03%，成交量1.14万手，成交额2920.21万元。当日关注点交易信息汇总：8月3日主力资金净流入157.3万元，占总成交额5.39%。公司公告汇总关于回购公司股份的进展公告截至2026年7月31日，优宁维通过集中竞价交易方式累计回购股份291,100股，占公司总股本的0.34%；最高成交价28.00元/股，最低成交价24.16元/股，支付总金额7,496,566元。回购价格上限已由45元/股调整为44.41元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400001582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655904758","title":"股市必读：优宁维（301166）7月29日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2655904758","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655904758?lang=zh_cn&edition=full","pubTime":"2026-07-30 01:58","pubTimestamp":1785347894,"startTime":"0","endTime":"0","summary":"截至2026年7月29日收盘，优宁维报收于24.66元，上涨0.65%，换手率2.15%，成交量1.21万手，成交额2992.27万元。董秘最新回复投资者： 万邦医药3亿元收购公司，市值增长40亿。2026年6月26日，万邦医药公告，公司拟以现金3.02亿元收购安徽赛德盛医药科技有限公司75.52%股权，溢价率约为394.58%。万邦医药称，本次收购是为了完善在创新药板块的业务布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000001036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655858607","title":"优宁维：公司围绕抗体及相关领域，寻找与公司业务具有协同效应的上下游企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2655858607","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655858607?lang=zh_cn&edition=full","pubTime":"2026-07-29 11:33","pubTimestamp":1785295989,"startTime":"0","endTime":"0","summary":"证券之星消息，优宁维07月29日在投资者关系平台上答复投资者关心的问题。五洲医疗周二公告，拟收购旋智科技100%股权，切入电机控制芯片领域，其股价截至周五收盘连续斩获三个20cm涨停。公司围绕抗体及相关领域，寻找与公司业务具有协同效应的上下游企业，如有相关进展公司将会严格按照信息披露的相关要求披露，投资者可关注公司后续在巨潮资讯网披露的相关公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900015530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654883700","title":"优宁维（301166）披露第一期员工持股计划非交易过户完成公告，7月28日股价下跌1.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654883700","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654883700?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:46","pubTimestamp":1785249972,"startTime":"0","endTime":"0","summary":"截至2026年7月28日收盘，优宁维报收于24.5元，较前一交易日下跌1.33%，最新总市值为21.11亿元。公司于近日披露《第一期员工持股计划非交易过户完成的公告》。公告显示，2026年7月24日，公司回购专用账户中881,200股股份非交易过户至员工持股计划专用账户，占公司总股本的1.02%，过户价格为15.30元/股。本次持股计划实际认购金额为13,482,360元，资金来源为员工合法薪酬及自筹资金。公司已开立员工持股计划证券账户，相关股份过户已完成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800040204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791494676809,"stockEarnings":[{"period":"1week","weight":-0.0068},{"period":"1month","weight":0.2028},{"period":"3month","weight":0.3219},{"period":"6month","weight":0.1697},{"period":"1year","weight":0.1577},{"period":"ytd","weight":0.2084}],"compareEarnings":[{"period":"1week","weight":-0.0079},{"period":"1month","weight":-0.0326},{"period":"3month","weight":-0.0461},{"period":"6month","weight":-0.0437},{"period":"1year","weight":-0.0183},{"period":"ytd","weight":-0.0395}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海优宁维生物科技股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"9482人(较上一季度减少18.45%)","perCapita":"5950股","listingDate":"2021-12-28","address":"上海市杨浦区控江路1690号1505室","registeredCapital":"8616万元","survey":" 上海优宁维生物科技股份有限公司的主营业务是提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。公司的主要产品是生命科学试剂及相关仪器、耗材、综合技术服务。","listedPrice":86.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"优宁维(301166)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供优宁维(301166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"优宁维,301166,优宁维股票,优宁维股票老虎,优宁维股票老虎国际,优宁维行情,优宁维股票行情,优宁维股价,优宁维股市,优宁维股票价格,优宁维股票交易,优宁维股票购买,优宁维股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"优宁维(301166)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供优宁维(301166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}